|
|
News Breaks | | | | October 5, 2012 | | 11:27 EDT |  | WPI | Watson acquisition of Actavis approved by European Commission
The European Commission has cleared under the EU Merger Regulation the proposed acquisition of the Swiss-based pharmaceutical company Actavis by Watson of the U.S. The Commission concluded that the merged entity will continue to face a number of strong competitors. The Commission examined the effects of the proposed transaction on the markets for a number of drugs, such as anti-depressants and anti-hypertensives, in particular in Denmark, Sweden and the UK. The investigation showed that despite significant changes in the competitive situation in some of the markets, a sufficient number of credible and strong competitors will continue to exercise a competitive constraint on the merged entity. | |
|
News For WPI From The Last 14 Days Check below for free stories on WPI the last two weeks. |
|
|
| There are no results for WPI |
|
|
|
|
|
|
